RNA-Based Therapeutics and Vaccines Market
RNA-Based Therapeutics and Vaccines Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
RNA-Based Therapeutics and Vaccines Market Size and Growth
The RNA-based therapeutics and vaccines market is experiencing significant growth, driven by advancements in mRNA technology and increasing investments in gene therapies. The market is projected to reach approximately $150 billion by 2030, with rising demand for innovative treatments and preventive measures, particularly in response to emerging infectious diseases and genetic disorders.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Alnylam Pharmaceuticals
◍ Arbutus Biopharma
◍ Arrowhead Pharmaceuticals
◍ BioNTech
◍ CureVac
◍ Dicerna Pharmaceuticals
◍ Regulus Therapeutics
◍ Marina Biotech
◍ MiRagen Therapeutics
◍ Moderna Therapeutics
◍ Quark Pharmaceuticals
◍ Roche
◍ Sylentis
The RNA-based therapeutics and vaccines market is expanding, driven by companies like Moderna and BioNTech (mRNA vaccines), Alnylam (siRNA), and Regulus (miRNA). These firms enhance treatment options, innovate delivery methods, and improve patient outcomes, fostering market growth. Notable revenues include Moderna ($18.5 billion) and BioNTech ($4.1 billion).
Request Sample Report
